GoHealth, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that GoHealth, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Net Income — By Quarter
| Quarter | Fiscal Year | Period End | Value | Filed |
|---|---|---|---|---|
| Q3 | 2025 | Sep 30, 2025 | ($165.85M) | Nov 14, 2025 |
| Q2 | 2025 | Jun 30, 2025 | ($54.28M) | Aug 12, 2025 |
| Q1 | 2025 | Mar 31, 2025 | ($4.41M) | May 16, 2025 |
| Q3 | 2025 | Sep 30, 2024 | $6.78M | Nov 14, 2025 |
| Q2 | 2025 | Jun 30, 2024 | ($26.00M) | Aug 12, 2025 |
| Q1 | 2025 | Mar 31, 2024 | ($9.22M) | May 16, 2025 |
| Q3 | 2024 | Sep 30, 2023 | ($23.91M) | Nov 7, 2024 |
| Q2 | 2024 | Jun 30, 2023 | ($28.94M) | Aug 8, 2024 |
| Q1 | 2024 | Mar 31, 2023 | ($9.18M) | May 9, 2024 |
| Q3 | 2023 | Sep 30, 2022 | ($30.01M) | Nov 9, 2023 |
| Q2 | 2023 | Jun 30, 2022 | ($43.82M) | Aug 10, 2023 |
| Q1 | 2023 | Mar 31, 2022 | ($13.48M) | May 9, 2023 |
| Q3 | 2022 | Sep 30, 2021 | ($20.24M) | Nov 14, 2022 |
| Q2 | 2022 | Jun 30, 2021 | ($12.00M) | Aug 16, 2022 |
| Q1 | 2022 | Mar 31, 2021 | ($2.09M) | May 10, 2022 |
| Q3 | 2021 | Sep 30, 2020 | ($56.42M) | Nov 10, 2021 |
| Q2 | 2021 | Jun 30, 2020 | ($22.87M) | Aug 12, 2021 |
| Q1 | 2021 | Mar 31, 2020 | ($937.0K) | May 13, 2021 |
| Q3 | 2020 | Sep 30, 2019 | ($11.71M) | Nov 13, 2020 |
| Q3 | 2020 | Sep 12, 2019 | ($77.34M) | Nov 13, 2020 |
Operating Income — By Quarter
| Quarter | Fiscal Year | Period End | Value | Filed |
|---|---|---|---|---|
| Q3 | 2025 | Sep 30, 2025 | ($287.92M) | Nov 14, 2025 |
| Q2 | 2025 | Jun 30, 2025 | ($99.39M) | Aug 12, 2025 |
| Q1 | 2025 | Mar 31, 2025 | $6.67M | May 16, 2025 |
| Q3 | 2025 | Sep 30, 2024 | ($42.67M) | Nov 14, 2025 |
| Q2 | 2025 | Jun 30, 2024 | ($40.61M) | Aug 12, 2025 |
| Q1 | 2025 | Mar 31, 2024 | ($4.03M) | May 16, 2025 |
| Q3 | 2024 | Sep 30, 2023 | ($37.98M) | Nov 7, 2024 |
| Q2 | 2024 | Jun 30, 2023 | ($53.02M) | Aug 8, 2024 |
| Q1 | 2024 | Mar 31, 2023 | ($5.75M) | May 9, 2024 |
| Q3 | 2023 | Sep 30, 2022 | ($59.14M) | Nov 9, 2023 |
| Q2 | 2023 | Jun 30, 2022 | ($101.04M) | Aug 10, 2023 |
| Q1 | 2023 | Mar 31, 2022 | ($25.31M) | May 9, 2023 |
| Q3 | 2022 | Sep 30, 2021 | ($48.71M) | Nov 14, 2022 |
| Q2 | 2022 | Jun 30, 2021 | ($19.00M) | Aug 16, 2022 |
| Q1 | 2022 | Mar 31, 2021 | $1.41M | May 10, 2022 |
| Q3 | 2021 | Sep 30, 2020 | ($197.80M) | Nov 10, 2021 |
| Q2 | 2021 | Jun 30, 2020 | ($14.41M) | Aug 12, 2021 |
| Q1 | 2021 | Mar 31, 2020 | $5.83M | May 13, 2021 |
| Q3 | 2020 | Sep 30, 2019 | ($10.46M) | Nov 13, 2020 |
| Q3 | 2020 | Sep 12, 2019 | ($77.32M) | Nov 13, 2020 |